Federated Hermes’s Avadel Pharmaceuticals AVDL Stock Holding History

Federated Hermes’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-101,711	Closed	-$2.19M	–	2067
2025 Q4	$2.19M	Buy	101,711 +98,240	+2,830%	+$1.91M	﹤0.01%	945
2025 Q3	$53K	Buy	3,471 +2,296	+195%	+$29.9K	﹤0.01%	1653
2025 Q2	$10.4K	Buy	+1,175	New	+$10.3K	﹤0.01%	1813
2020 Q2	–	Sell	-88	Closed	-$1K	–	2243
2020 Q1	$1K	Buy	+88	New	+$676	﹤0.01%	2079

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Federated Hermes's AVDL Position: Q1 2026 in Review

Federated Hermes sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 101,711 shares — an estimated $2.19M sold.

Federated Hermes first reported a position in AVDL in Q1 2020 and held it in 4 quarters. The position peaked at $2.19M in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

Federated Hermes reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Federated Hermes sold 101,711 Avadel Pharmaceuticals shares in Q1 2026, an estimated $2.19M.
Federated Hermes first reported a position in Avadel Pharmaceuticals in Q1 2020 and held it in 4 quarters.
Federated Hermes's Avadel Pharmaceuticals position peaked at $2.19M in Q4 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.